Susquehanna International Group, LLP Ambrx Biopharma Inc. Put Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$9.3 - $16.6 $442,680 - $790,160
47,600 Added 98.76%
95,800 $1.1 Million
Q2 2023

Aug 11, 2023
SELL
$7.66 - $16.46 $29,108 - $62,548
-3,800 Reduced 7.31%
48,200 $793,000
Q1 2023

May 16, 2023
BUY
$1.46 - $12.54 $6,716 - $57,683
4,600 Added 9.7%
52,000 $463,000
Q4 2022

Feb 14, 2023
BUY
$0.41 - $4.54 $19,434 - $215,196
47,400 New
47,400 $107,000

Others Institutions Holding AMAM

# of Institutions
2
Shares Held
31.2K
Call Options Held
0
Put Options Held
0
View Full List

About Ambrx Biopharma Inc.

AMAM Quotes by TradingView
  • Ticker AMAM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,618,400
  • Market Cap $1.08B
  • Description
  • Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gas...
More about AMAM
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email